Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Base de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Surg Neurol Int ; 13: 260, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35855143

RESUMEN

Background: How long do nonoperative cervical fractures have to be followed and with how many imaging studies? Methods: We reviewed 69 adult patients with 122 (31 occiptocervical and 91 sub-axial) cervical fractures; at least one of the cervical fractures was managed nonoperatively. Outcomes were assessed along with the optimal follow-up duration and frequency of various diagnostic studies. Results: An average of four follow-up visits occurred on average 28-, 66-, 94-, and 158-day post hospital discharge. The average time between discharge and orthotic clearance was 70 days (±32.4 days). Radiographic studies were obtained at follow-up visits, respectively, in, 82.6%, 83.6%, 94.7%, and 100% of patients. Conclusion: The trend for managing nonoperative cervical fractures was an unduly prolonged follow-up duration that included obtaining too many imaging studies.

2.
Neurooncol Adv ; 4(1): vdac008, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35300149

RESUMEN

The response assessment in neuro-oncology (RANO) criteria have been the gold standard for monitoring treatment response in glioblastoma (GBM) and differentiating tumor progression from pseudoprogression. While the RANO criteria have played a key role in detecting early tumor progression, their ability to identify pseudoprogression is limited by post-treatment damage to the blood-brain barrier (BBB), which often leads to contrast enhancement on MRI and correlates poorly to tumor status. Amino acid positron emission tomography (AA PET) is a rapidly growing imaging modality in neuro-oncology. While contrast-enhanced MRI relies on leaky vascularity or a compromised BBB for delivery of contrast agents, amino acid tracers can cross the BBB, making AA PET particularly well-suited for monitoring treatment response and diagnosing pseudoprogression. The authors performed a systematic review of PubMed, MEDLINE, and Embase through December 2021 with the search terms "temozolomide" OR "Temodar," "glioma" OR "glioblastoma," "PET," and "amino acid." There were 19 studies meeting inclusion criteria. Thirteen studies utilized [18F]FET, five utilized [11C]MET, and one utilized both. All studies used static AA PET parameters to evaluate TMZ treatment in glioma patients, with nine using dynamic tracer parameters in addition. Throughout these studies, AA PET demonstrated utility in TMZ treatment monitoring and predicting patient survival.

3.
Neurooncol Adv ; 3(1): vdab003, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34409294

RESUMEN

BACKGROUND: Currently, bevacizumab (BEV), an antiangiogenic agent, is used as an adjunctive therapy to re-irradiation and surgery in patients with recurrent high-grade gliomas (rHGG). BEV has shown to decrease enhancement on MRI, but it is often unclear if these changes are due to tumor response to BEV or treatment-induced changes in the blood brain barrier. Preliminary studies show that amino acid PET can aid in distinguishing these changes on MRI. METHODS: The authors performed a systematic review of PubMed and Embase through July 2020 with the search terms 'bevacizumab' or 'Avastin' and 'recurrent glioma' and 'PET,' yielding 38 papers, with 14 meeting inclusion criteria. RESULTS: Thirteen out of fourteen studies included in this review used static PET and three studies used dynamic PET to evaluate the use of BEV in rHGG. Six studies used the amino acid tracer [18F]FET, four studies used [11C]MET, and four studies used [18F]FDOPA. CONCLUSION: [18F]FET, [11C]MET, and [18F]FDOPA PET in combination with MRI have shown promising results for improving accuracy in diagnosing tumor recurrence, detecting early treatment failure, and distinguishing between tumor progression and treatment-induced changes in patients with rHGG treated with BEV.

4.
J Clin Neurosci ; 90: 14-20, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34275538

RESUMEN

Giant intracranial aneurysms represent a complex pathology that pose challenges for management, especially in the pediatric population. With emerging endovascular techniques, combined endovascular and open surgical approaches may be a favorable alternative for complex cases. In this systematic review, we characterize the treatment modalities of giant aneurysms in the pediatric population and provide an update on the number of giant aneurysms reported in the literature by anatomic location. We conducted a literature search of PubMed, Embase, and Medline databases with the following terms: 'pediatric' AND 'giant' AND 'intracranial aneurysm.' Studies were included if data on treatment modality and aneurysm location were available for pediatric patients with giant intracranial aneurysms. The literature search yielded a total of 188 papers, with 82 pediatric patients from 33 articles ultimately meeting inclusion criteria. There were significantly more male than female patients (p = 0.011), with 52 and 29 respectively. Patients presenting with a ruptured aneurysm were significantly younger than patients presenting without rupture (p = 0.018), with a median age of 8.0 and 12.0 years, respectively. There were 45 giant aneurysms reported in the anterior circulation and 37 in the posterior circulation. Anterior aneurysms were most often treated with surgical approaches, while posterior aneurysms were typically treated with endovascular interventions (p = 0.002). Although combined surgical and endovascular approaches were the least frequently utilized, we suggest a combined approach may be particularly useful for patients with complex cases that require a management plan tailored to their needs.


Asunto(s)
Aneurisma Intracraneal/epidemiología , Aneurisma Intracraneal/cirugía , Aneurisma Roto/cirugía , Revascularización Cerebral/métodos , Niño , Embolización Terapéutica/métodos , Procedimientos Endovasculares/métodos , Femenino , Humanos , Incidencia , Masculino , Procedimientos Neuroquirúrgicos/métodos , Resultado del Tratamiento
5.
Invert Neurosci ; 19(3): 9, 2019 07 31.
Artículo en Inglés | MEDLINE | ID: mdl-31367776

RESUMEN

Scorpion pectines detect chemical and physical stimuli via thousands of peg sensilla on ground-facing teeth. Each sensillum has multiple neurons that detect stimuli and transmit neural impulses to the subesophageal ganglion (SEG) in the central nervous system. Anatomically, the organization of the pectinal neuropil in the SEG reflects the arrangement of pectinal teeth, suggesting conservation of information about stimulus location in the SEG. In this study, neural impulses from the pectinal nerve of the striped bark scorpion (Centruroides vittatus) were recorded in the pecten, abdominal cavity, and SEG using electrophysiology. Recordings from the right pectinal nerve in the pecten showed that right tooth stimulations elicit sensory activity milliseconds before motor feedback, while left tooth stimulations only evoked motor spikes, suggesting no contralateral afferent communication between pectines. In the abdominal cavity recordings, two distinct waveforms (PN1 and PN2) were detected in baseline activity; PN1 seemed to enhance the likelihood that PN2 would fire, suggesting a possible excitatory interaction. Recordings from the SEG showed that mechanically stimulating different pectinal teeth evoked different compound neural activity patterns in the same SEG location. Stimulating the same tooth in succession showed mechanosensory adaptation. These recordings show promise for continued electrophysiological investigations of the scorpion SEG, and, in particular, how information from the pectines is processed and used for orientation.


Asunto(s)
Ganglios de Invertebrados/fisiología , Mecanotransducción Celular/fisiología , Escorpiones/fisiología , Sensilos/fisiología , Animales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA